.jpg)
As per EGX efforts to work with the listed companies to adjust their positions to comply with listing and de-listing rules, and in the light of the close review of the suspended companies on a regular basis and sending the results to the listing committee respectively, the listing committee held on 16/09/2014 decided to resume trading on the listed company (October Pharma) after being suspended for a period of more than 2 years since 03/05/2012 due to non-renewal of its legal term which had ended on 10/04/2012 and the subsequent judicial disputes, specially with regard to the board of directors formation.
The company has fulfilled the most important fundamental data and disclosures needed to resume trading on its shares, which included the minutes of the AGM and EGM held on 15/06/2014 (certified) and the latest commercial record as well as the financial statements for the financial periods 30/09/2012 - 31/12/2012 ? 31/03/2013 - 30/06/2013 ? 30/09/2013 ? 31/12/2013 ? 31/03/2014 and 30/06/2014.
Trading will start on the company's shares as of Sunday 21 /9/2014.
